Initiation and continued use of oral pre-exposure prophylaxis among pregnant and postpartum women in South Africa (PrEP-PP): a demonstration cohort study

By sjmartinez • October 31, 2024

Joseph Davey DL, Mvududu R, Mashele N, Bheemraj K, Khadka N, Johnson LF, Dean SS, Gorbach P, Bekker LG, Coates TJ, Myer L. Initiation and continued use of oral pre-exposure prophylaxis among pregnant and postpartum women in South Africa (PrEP-PP): a demonstration cohort study. Lancet HIV. 2024 Nov;11(11):e746-e755. doi: 10.1016/S2352-3018(24)00240-6. PMID: 39477557.

Tags: Infectious Diseases, Publications

MUCOR-ADVANCE: Uniting multidisciplinary science to defeat a deadly fungus

Wurster S, Stewart AG, Gu Y, Youssef EG, John TM, Uppuluri P, Chamilos G, Filler S, Bruno V, Ibrahim AS, Kontoyiannis DP; MUCOR-ADVANCE consortium. MUCOR-ADVANCE:[...]

“We’ll Just Warm Ourselves up with Drugs”: Polysubstance Use among Sexual and Gender Minority Persons (SGMP) Who Inject Drugs in Los Angeles, California

Smeltzer RP, Orta Portillo GA, Ganesh SS, Koerber J, Gould EE, Bolanos R, Gorbach PM, Bluthenthal RN. "We'll Just Warm Ourselves up with Drugs": Polysubstance[...]

Mixed Models, Not Mixed Messaging: Reply to Haddad, et al

Graber CJ, Ranson EL, Landovitz RJ, Branch-Elliman W. Mixed Models, Not Mixed Messaging: Reply to Haddad, et al. Clin Infect Dis. 2026 Oct 27:ciag681. doi:[...]